Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 62 results for "biocon under kiran mazumdar shaw"

Kiran Mazumdar-Shaw urges PM Narendra Modi to cure pharma sector
Financial Express

Heal pharma sector, Kiran Mazumdar urges PM

Kiran Mazumdar-Shaw, chairperson of the Confederation of Indian Industry's national committee on biotechnology, has written an open letter to the Prime Minister asking him to intervene to cure the pharma sector of its ailments. Mazumdar-Shaw, also ... Smart Investor, 2 weeks ago

69 images for biocon under kiran mazumdar shaw

APN News, 1 week ago
Financial Express, 3 weeks ago
NDTV, 3 weeks ago, 4 weeks ago
Reuters, 1 month ago
New Indian Express, 3 weeks ago
Asian Scientist, 1 month ago
Asian Lite, 1 month ago
News India Times, 1 month ago
Business Today India, 2 months ago

Biocon Announces Q1 FY15 Results

Commenting on the quarterly performance and highlights, Chairman and Managing Director, Kiran Mazumdar-Shaw stated, Our revenue growth this quarter has been muted. Our business performance reflects the challenges that we are temporarily facing in ...
 Businessworld India3 weeks ago Biocon : announces Q1 FY15 results...  4 Traders3 weeks ago
NDTV Profit

Industry Body Seeks Prime Minister's Intervention Over Drug Price Fixing

File photo of Biocon chief Kiran Mazumdar-Shaw New Delhi : Industry chamber CII has sought Prime Minister Narendra Modi's intervention over "unilateral fixing" of drug prices by the National Pharmaceutical Pricing Authority (NPPA) saying the ...
 NDTV Profit3 weeks ago

Kiran Mazumdar-Shaw awarded Kiel Institute's 2014 Global Economy Prize

Bangalore, June 23 : Kiran Mazumdar-Shaw, Chairperson and Managing Director of Biocon Ltd, Asia's leading bio-pharmaceutical company, has been awarded the Kiel Institute's most coveted '2014 Global Economy Prize' for business during the 100th ...
 Topnews.in1 month ago Biocon chief Kiran Mazumdar-Shaw gets Kiel Institute's '2014 Global Economy Prize  PharmaBiz1 month ago

Price control debate: Is the pharma sector crying 'wolf'?

T Also Read: See more drug price caps; max impact on Sanofi: Expert CNBC-TV18's Shereen Bhan spoke to Kiran Mazumdar Shaw, CMD of Biocon and Mr CM Gulati, Researcher at IMS Health India to get their perspective on how the government's new move ...
 Moneycontrol.com1 month ago

Biocon chief seeks PM's intervention to solve issues being faced by pharma industry

The National Pharmaceutical Pricing Authority's (NPPA) decision to impose ceiling prices on 348 essential drugs under the National List of Essential Medicines (NLEM), by adopting a simple average price formula, has been to the industry's ...
 PharmaBiz3 weeks ago

Biocon net up by 10% in Q1 to Rs. 103 crore

Biocon, a Rs. 2,850 crore plus fully integrated, innovation-led, emerging global biopharmaceutical company from Bengaluru, has posted net profit growth of 9.6 per cent for the first quarter ended June 2014 to Rs. 103 crore from Rs. 94 crore in the ...
 PharmaBiz3 weeks ago Biocon Q1 net up 9%  Business Standard India3 weeks ago

BIOCON : files first new drug applications

Mumbai : Bangalore -based Biocon on Friday said it has filed its first abbreviated new drug applications (ANDAs) targeting the US generics market during the June quarter. Kiran Mazumdar-Shaw , chairman and managing director, said, "We have filed ...
 4 Traders3 weeks ago Biocon files its first new drug applications  DNA India3 weeks ago Biocon files first new drug applications [DNA : Daily News & Analysis (India)]  Pharmacy Choice3 weeks ago

West Asia turmoil mutes Biocon's earnings in Q1

BANGALORE: Biocon reported a modest 9% growth in profit on a 3% growth in revenue for the April to June first quarter of fiscal 2015, as compared to the same period a year ago. Challenges in the key growth markets of Middle East and North Africa ...
 Times of India3 weeks ago Biocon : West Asia turmoil mutes Biocon's earnings in Q1  4 Traders3 weeks ago

Biocon net up nine percent in Q1

Bangalore, July 25 India's biotech major Biocon Ltd. reported net profit of Rs.103 crore for the first quarter (April-June) of fiscal 2014-15, registering nine percent year-on-year (YoY) growth from Rs.94 crore in the same quarter last year.
 ProKerala.com3 weeks ago Biocon Q1 Net Profit Rises 10%  RTTNews.com3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - biocon under kiran mazumdar shaw
Get updated on latest news & your favorite topics right in your inbox!
More     Less